WO2000021577A3 - Compositions - Google Patents
Compositions Download PDFInfo
- Publication number
- WO2000021577A3 WO2000021577A3 PCT/GB1999/003344 GB9903344W WO0021577A3 WO 2000021577 A3 WO2000021577 A3 WO 2000021577A3 GB 9903344 W GB9903344 W GB 9903344W WO 0021577 A3 WO0021577 A3 WO 0021577A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- contrast agents
- particulate compositions
- compositions
- vesicles
- enhance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
- A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU62171/99A AU6217199A (en) | 1998-10-09 | 1999-10-08 | Compositions |
GB0016470A GB2349335A (en) | 1998-10-09 | 1999-10-08 | Compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9822158.3A GB9822158D0 (en) | 1998-10-09 | 1998-10-09 | Compositions |
GB9822158.3 | 1998-10-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000021577A2 WO2000021577A2 (en) | 2000-04-20 |
WO2000021577A3 true WO2000021577A3 (en) | 2000-07-27 |
Family
ID=10840358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/003344 WO2000021577A2 (en) | 1998-10-09 | 1999-10-08 | Compositions |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6217199A (en) |
GB (2) | GB9822158D0 (en) |
WO (1) | WO2000021577A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004529161A (en) | 2001-05-04 | 2004-09-24 | トゥラリック インコーポレイテッド | Fused heterocyclic compounds |
US6809104B2 (en) | 2001-05-04 | 2004-10-26 | Tularik Inc. | Fused heterocyclic compounds |
CN1335182A (en) * | 2001-08-08 | 2002-02-13 | 华中科技大学 | Insulin spray for oral cavity and its prepn process |
US20040067221A1 (en) * | 2002-05-22 | 2004-04-08 | Medtronic, Inc. | Cell delivery fluid for prevention of cell settling in delivery system |
US20050287125A1 (en) * | 2002-05-22 | 2005-12-29 | Medtronic, Inc. | Cell delivery fluid for prevention of cell settling in delivery system |
CN101134757A (en) | 2002-11-06 | 2008-03-05 | 安姆根有限公司 | Fused heterocyclic compounds |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2613172A (en) * | 1949-08-10 | 1952-10-07 | American Cystoscope Makers Inc | X-ray contrast compositions |
WO1980001244A1 (en) * | 1978-12-19 | 1980-06-26 | Bykgulden Lomberg Chem Fab | X-ray contrast media solutions |
EP0128578A1 (en) * | 1983-06-14 | 1984-12-19 | Byk Gulden Lomberg Chemische Fabrik GmbH | Ethanolic suspensions of contrast agents |
EP0602691A2 (en) * | 1992-12-15 | 1994-06-22 | NanoSystems L.L.C. | Controlled precipitation of particulate diagnostic imaging contrast agents |
WO1996007434A1 (en) * | 1994-09-06 | 1996-03-14 | Marsden, John, Christopher | Improvements in or relating to contrast agents |
WO1997006132A1 (en) * | 1995-08-10 | 1997-02-20 | Nanosystems L.L.C. | Triiodoalkylphenyl esters as novel x-ray contrast agents |
WO1997036576A1 (en) * | 1996-04-01 | 1997-10-09 | Korea Institute Of Science And Technology | Preparation method of emulsion for chemoembolization |
WO1998041239A1 (en) * | 1997-03-14 | 1998-09-24 | Nycomed Imaging As | Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier |
WO1998048847A1 (en) * | 1997-04-25 | 1998-11-05 | Nycomed Imaging As | Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization |
-
1998
- 1998-10-09 GB GBGB9822158.3A patent/GB9822158D0/en not_active Ceased
-
1999
- 1999-10-08 WO PCT/GB1999/003344 patent/WO2000021577A2/en active Application Filing
- 1999-10-08 AU AU62171/99A patent/AU6217199A/en not_active Abandoned
- 1999-10-08 GB GB0016470A patent/GB2349335A/en not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2613172A (en) * | 1949-08-10 | 1952-10-07 | American Cystoscope Makers Inc | X-ray contrast compositions |
WO1980001244A1 (en) * | 1978-12-19 | 1980-06-26 | Bykgulden Lomberg Chem Fab | X-ray contrast media solutions |
EP0128578A1 (en) * | 1983-06-14 | 1984-12-19 | Byk Gulden Lomberg Chemische Fabrik GmbH | Ethanolic suspensions of contrast agents |
EP0602691A2 (en) * | 1992-12-15 | 1994-06-22 | NanoSystems L.L.C. | Controlled precipitation of particulate diagnostic imaging contrast agents |
WO1996007434A1 (en) * | 1994-09-06 | 1996-03-14 | Marsden, John, Christopher | Improvements in or relating to contrast agents |
WO1997006132A1 (en) * | 1995-08-10 | 1997-02-20 | Nanosystems L.L.C. | Triiodoalkylphenyl esters as novel x-ray contrast agents |
WO1997036576A1 (en) * | 1996-04-01 | 1997-10-09 | Korea Institute Of Science And Technology | Preparation method of emulsion for chemoembolization |
WO1998041239A1 (en) * | 1997-03-14 | 1998-09-24 | Nycomed Imaging As | Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier |
WO1998048847A1 (en) * | 1997-04-25 | 1998-11-05 | Nycomed Imaging As | Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization |
Non-Patent Citations (4)
Title |
---|
BOHLE FLORIAN ET AL: "New iodinated contrast agents: The physicochemical and biological properties of asymmetric dimers.", INVESTIGATIVE RADIOLOGY 1994, vol. 29, no. SUPPL. 2, 1994, pages S264 - S266, XP000906758, ISSN: 0020-9996 * |
DICK ARMIN ET AL: "Computed tomography of experimental liver abscesses using a new liposomal contrast agent.", INVESTIGATIVE RADIOLOGY 1996, vol. 31, no. 4, 1996, pages 194 - 203, XP000906757, ISSN: 0020-9996 * |
HORI S ET AL: "NEW CONTRAST MATERIAL FOR CT OF THE LIVER AND SPLEEN USING IODINATED OIL EMULSIFIED BY A NON-IONIC CONTRAST MATERIAL", NIPPON ACTA RADIOLOGICA 1988, vol. 48, no. 12, 1988, pages 1503 - 1510, XP000906834, ISSN: 0048-0428 * |
KANEMATSU MASAYUKI: "Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-lipiodol emulsion (EMILE) for hepatocellular carcinoma.", JOURNAL OF GASTROENTEROLOGY 1995, vol. 30, no. 2, 1995, pages 215 - 223, XP000906736 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000021577A2 (en) | 2000-04-20 |
GB0016470D0 (en) | 2000-08-23 |
GB2349335A (en) | 2000-11-01 |
GB9822158D0 (en) | 1998-12-02 |
AU6217199A (en) | 2000-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA986489B (en) | Stable liquid composition comprising high levels of emollients. | |
EP0680694A3 (en) | Compositions of fluorescent biocides for use in aqueous systems. | |
HUP9903174A2 (en) | Pharmaceutical composition comprising coenzyme q10 | |
PL322175A1 (en) | Oral pharmaceutic administration forms containing the protonic pump inhibitor and either an acid neutralising agent or alginate | |
HU9800056D0 (en) | Liquid gonadotropin containing formulations | |
AU3820393A (en) | 2,4-dioxoimidazolidine derivatives | |
EG23820A (en) | Liquid formulation with formoterol suitable for storage | |
CA2148583A1 (en) | Viscoelastic Surfactant Based Foam Fluids | |
CA2326756A1 (en) | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients | |
AU2002892A (en) | Porous inorganic ultrasound contrast agents | |
ZA979961B (en) | 5-HT1F agonists | |
ZA983167B (en) | Liquid antacid compositions. | |
EP1086701A3 (en) | Simethicone containing laxative composition | |
WO2002048142A1 (en) | Medicinal compositions having improved absorbability | |
IL115442A0 (en) | Liquid antacid compositions | |
WO2000021577A3 (en) | Compositions | |
CA2178163A1 (en) | Water soluble granular compositions comprising an imidazolinone herbicide and a base | |
GB2340256B (en) | Use of alkoxy N-Hydroxyalkyl alkanamide as resist removing agent composition for removing resist method for preparing the same and resist removing method. | |
HUP9702480A3 (en) | New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same | |
BR9809905A (en) | Compound, composition, use of it, and process for its preparation | |
AU2000261384A1 (en) | Porous agglomerates containing iron and at least one further element from groups5 or 6 of the periodic table for use as an alloying agent | |
ZA9997B (en) | Stabilization of Lipid: DNA Formulations during Nebulization. | |
PL340459A1 (en) | Agonists of 5ht1f | |
CA2282893A1 (en) | Heat stable antacid and antigas suspensions | |
HUP9702479A3 (en) | New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09589091 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: GB Ref document number: 200016470 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |